CohBar Has Received A Notice Of Allowance For Its U.S. Patent Application Titled "THERAPEUTIC PEPTIDES (FOR THE TREATMENT OF METABOLIC DISEASE, CANCER, LIVER DISEASE, AND METHODS OF MODULATING FATTY ACID METABOLISM)"
CohBar Has Received A Notice Of Allowance For Its U.S. Patent Application Titled "THERAPEUTIC PEPTIDES (FOR THE TREATMENT OF METABOLIC DISEASE, CANCER, LIVER DISEASE, AND METHODS OF MODULATING FATTY ACID METABOLISM)"
CohBar 已收到允許其名爲 “治療肽（用於治療代謝性疾病、癌症、肝臟疾病和調節脂肪酸代謝的方法）” 的美國專利申請的批准通知
CohBar Has Received A Notice Of Allowance For Its U.S. Patent Application Titled "THERAPEUTIC PEPTIDES (FOR THE TREATMENT OF METABOLIC DISEASE, CANCER, LIVER DISEASE, AND METHODS OF MODULATING FATTY ACID METABOLISM)"
CohBar 已收到允許其名爲 “治療肽（用於治療代謝性疾病、癌症、肝臟疾病和調節脂肪酸代謝的方法）” 的美國專利申請的批准通知
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。